Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-19

Clinical Trial Update: High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing high versus standard heparin dosing for prevention of forearm artery occlusion during coronary angiography has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Heparin (unfractionated heparin)

Snippet

Sponsor: University of Patras | Conditions: Coronary Angiography | Phase 4 | Status: COMPLETED